Li Yang

This inventor holds 37 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Gene Editing Technologies. Top assignees: Huawei Technologies Co., Limited, Shanghaitech University, Graphic Packaging International, Inc.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Yang. Retrieved from https://idiyas.com/inventor/li-yang-bkna8x7z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 20)

% Patents Active = 81.1

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 141(Granted Patents)

Location History:

Chengdu, CN (2011)
Beijing, CN (2013)
London, GB (2021)
Reading, GB (2021)
Shanghai, CN (2015 - 2024)

Company Filing History:

15 out of 27,557

Huawei Technologies Co., Limited

patents

4 out of 88

Shanghaitech University

patents

3 out of 1,006

Graphic Packaging International, Inc.

patents

4. 3 out of 166,351

International Business Machines Corporation

patents

5. 2 out of 3,358

Chinese Academy of Sciences

patents

6. 2 out of 16,049

Honeywell International Inc.

patents

7. 2 out of 159

Jiangsu Hengrui Medicine Company Ltd.

patents

8. 2 out of 100

Shanghai Hengrui Pharmaceutical Co., Ltd.

Antimatter Research, Inc.

patents

11. 1 out of 689

Covestro Deutschland Ag

patents

12. 1 out of 1

Shanghai P & P Biotech Co., Ltd

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Circular RNA

Drug Treatment

Flow Conditioner

Gene Editing

Fusion Proteins

PD-1 Antibody

Data Transmission

Telepresence Device

Lithium-Ion Battery

Electrolyte Solvent

Tissue Regeneration

Communication Method

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383574 - Application of circular RNA in preparing drug for treating systemic lupus erythematosus (2025-08-12),

2. 12372391 - Flow conditioner for severe flow disturbances (2025-07-29),

3. 12286988 - Rectifier and flowmeter (2025-04-29),

4. 12203077 - Fusion proteins for improved precision in base editing (2025-01-21),

5. 12185231 - Network information reporting method and apparatus, user equipment, service node and medium (2024-12-31),

6. 11884947 - Fusion proteins for base editing (2024-01-30),

7. 11840685 - Inhibition of unintended mutations in gene editing (2023-12-12),

8. 11576218 - Data transmission method, terminal, and base station (2023-02-07),

9. 11485830 - Polycarbonate composite having an increased pencil hardness (2022-11-01),

10. 11384353 - Inhibition of unintended mutations in gene editing (2022-07-12),

11. 11365255 - PD-1 antibody, antigen-binding fragment thereof, and medical application thereof (2022-06-21),

12. 11184928 - System message transmission method, related device, and communications system (2021-11-23),

13. 11184804 - Data transmission method and apparatus (2021-11-23),

14. 11172416 - Method for accessing network by user equipment, and access device (2021-11-09),

15. 11057864 - Paging method, device, and system (2021-07-06),

Title: Innovations of Li Yang: Pioneering Base Editing Technologies

Introduction

Li Yang, based in Shanghai, China, is a prominent inventor known for his contributions to genetic editing technologies. With an impressive portfolio of 33 patents, he has been at the forefront of innovations that enhance precision in base editing techniques.

Latest Patents

Among his recent patents are groundbreaking advancements in the realm of base editing. One of his notable inventions is a set of fusion proteins designed for improved precision in base editing. These base editors incorporate a cytidine and a catalytically inactive version of Lachnospiraceae bacterium Cpf1 (LbCpf1), achieving significantly improved editing efficiency and fidelity compared to traditional Cas9-based editors. Additionally, he has developed fusion proteins that consist of an apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A) and a clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) protein, which can efficiently modify cytosines to uracils, even under challenging contexts like methylated sites.

Career Highlights

Li Yang has built a distinguished career, having worked with leading organizations such as Huawei Technologies Co., Limited and Shanghaitech University. His work in these entities has played a crucial role in advancing the field of genetics and biotechnology.

Collaborations

Throughout his career, Li Yang has collaborated with talented individuals, including his coworkers Hongzhuo Zhang and Tianle Deng. These partnerships have contributed to the successful development and implementation of innovative technologies in base editing.

Conclusion

Li Yang's extensive patent portfolio and his dedication to improving editing techniques make him a significant figure in the scientific community. His innovations not only advance the field of genetics but also pave the way for future breakthroughs in medical and agricultural applications.

Profile summary based on public USPTO records.